Cisplatin Eligibility and Maintenance Therapy in Metastatic Urothelial Carcinoma

Opinion
Video

The expert panel discusses how treatment strategies change based on cisplatin eligibility and the role of maintenance therapy in metastatic urothelial carcinoma.

Related Videos
Video 18 - "Reflecting on Differentiated Thyroid Cancer: Final Insights"
Video 17 - "Phase 2 ATLEP Trial Results"
Kian-Huat Lim, MD, PhD
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
Benjamin Garmezy, MD
Video 16 - "Neoadjuvant Approach in RAI-R-DTC"
Video 15 - "Addressing Unmet Needs and Challenges in RAI-R-DTC Treatment"
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
Related Content
Jay Simhan, MD, FACS, vice chair, Department of Urology, Fox Chase

Fox Chase Researchers Examine Effects of Radiation Therapy Timing on Lifespan of Artificial Urinary Sphincters

May 17th 2024
Article
Carrie L. Kitko, MD, associate professor, pediatrics, medical director, the Pediatric Stem Cell Transplantation Program, the Ingram Professor of Pediatric Oncology, Monroe Carell Jr. Children’s Hospital at Vanderbilt; Sagar S. Patel, MD, director, Communications and Media Relationships, the Division of Hematology, the University of Utah Huntsman Cancer Institute

Kitko and Patel Emphasize the Importance of GVHD Research and Awareness

February 19th 2024
Podcast
Michael B. Atkins, MD, deputy director, Georgetown Lombardi Comprehensive Cancer Center

Salvage Nivolumab/Ipilimumab Following Nivolumab Affords Treatment-Free Survival in RCC

May 11th 2024
Article
Yara Abdou, MD

Abdou Spotlights Factors Influencing ADC Treatment Selection in Breast Cancer

December 7th 2023
Podcast
Robert Wang, MD

Fox Chase Researchers Examine Alternative Methods of Specialized Imaging Scans for Kidney Masses

May 8th 2024
Article
Joemy Ramsay, PhD, researcher, Huntsman Cancer Institute; assistant professor, Division of Urology, the U

The Surprising Connection Between Male Infertility and Family Cancer Risk

May 6th 2024
Article